As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Christopher Filson is a urologic oncologist and health services researcher at the Kaiser Permanente Los Angeles Medical Center. He was appointed as a clinician investigator by the Southern California Permanente Medical Group in 2025. He is a Professor of Clinical Science at the Bernard J. Tyson Kaiser Permanente School of Medicine.
Dr. Filson’s research interests focus on optimizing the delivery of health care for patients with urologic cancer such as prostate cancer. The goal of ...
Being active can lower your risk of getting seriously ill with COVID, regardless of your race or the chronic conditions you may have, according to research published last year in the American Journal of Preventive Medicine.
The Kaiser Permanente Southern California findings were important, impactful, and influential. As a result, the journal editors chose the research article, “Associations of Physical Inactivity and COVID-19 Outcomes Among Subgroups,” as the American Journal of Preventive Medicine 2023 Article of the Year.
A Kaiser Permanente study of nearly 8,000 men shows that in mid- to late 2024, mpox was far more common among men who have sex with men than previously thought. Individuals without symptoms accounted for most infections and likely played a prominent role in transmission, contrary to prior assumptions that people had to be symptomatic ...
Taking doxycycline after sex helped prevent chlamydia and syphilis, but its ability to prevent gonorrhea faded over time as drug‑resistant strains became more common, according to new research. The findings show both the benefits and limits of a prevention strategy now widely used by patients, clinicians, and public health programs to prevent sexually transmitted infection ...
A large study conducted within Kaiser Permanente Southern California found that people with type 2 diabetes who primarily received diabetes self-management education and support were more likely to achieve healthy blood sugar levels than those whose care focused mainly on physician visits. “For people living with type 2 diabetes, this study shows that actively participating ...
This week, Nurses Week (May 6-12, 2026), we honor all the nurses who work within the Department of Research & Evaluation, who are a vital part of our research. Here we highlight Beatriz Alviso, RN, PHN, BSN who works in the Division of Health Services Research & Implementation Science. What is your background? I grew up ...
This week, Nurses Week (May 6-12, 2026), we honor all the nurses who work within the Department of Research & Evaluation, who are a vital part of our research. Here we highlight Christina Flores, LVN, who works in vaccine and infectious disease clinical trials. What is your background? I grew up in Highland Park, California, and ...
The latest IMPACT newsletter highlights Kaiser Permanente research and its real-world relevance. This issue explores why less frequent MS treatment may be just as effective, how staying active during pregnancy supports a healthier postpartum weight, and what new studies reveal about wildfire smoke risks. You’ll also find research on heart disease risk prediction across Asian ethnicities and a Q&A with Dr. Hui Zhou, reflecting on science, service, and being mom to this year’s Rose Queen.
Investigators with the Division of Epidemiologic Research apply rigorous research methods to address important health questions that have the potential to change clinical practice and health care delivery. The division’s research portfolio spans the care continuum, from etiology and prevention to survivorship and quality of life.
Division investigators have expertise in traditional epidemiologic studies, post-marketing safety and effectiveness studies, and outcomes research. Current research areas include cancer, cardiovascular disease, COVID-19, diabetes, infectious disease, molecular epidemiology, orthopedics and bone health, perinatal health, pharmacoepidemiology, and vaccines.